AstraZeneca says booster jab effective against Omicron

Published December 24, 2021
People pose with a needle in front of displayed AstraZeneca logo in this illustration taken December 11. — Reuters
People pose with a needle in front of displayed AstraZeneca logo in this illustration taken December 11. — Reuters

LONDON: British pharmaceutical giant AstraZeneca said on Thursday that a third, or “booster”, dose of its Covid-19 vaccine Vaxzevria “significantly” lifted antibody levels against the Omicron strain in a laboratory study.

AstraZeneca also revealed in other findings that its preventative moniclonal antibody treatment, Evusheld, “retains neutralisation activity” against Omicron.

The threat of the highly transmissible Omicron variant looms large over the festive holidays, forcing many governments to roll out new curbs and urge citizens to get vaccinated. However, separate UK research on Thursday suggested that Omicron infections are less likely to result in hospitalisation compared to the Delta variant.

“Vaxzevria significantly boosted levels of antibodies against the Omicron SARS-CoV-2 variant (B.1.1.529) following a third dose booster,” AstraZeneca said in a statement.

“The third dose booster vaccination neutralised the Omicron variant to levels that were broadly similar to those observed... after the second dose against the Delta variant.” Levels of neutralising antibodies were also higher with the booster jab than with individuals who had previously been infected and recovered naturally.

The study was conducted by investigators from the University of Oxford, which is the academic institution which helped AstraZeneca develop the vaccine last year.

Researchers analysed blood samples taken from individuals infected with Covid-19; those vaccinated with two doses plus a booster; and those who had reported previous infection. “It is very encouraging to see that current vaccines have the potential to protect against Omicron following a third dose booster,” said University of Oxford professor John Bell, one of the study investigators.

Published in Dawn, December 24th, 2021

Opinion

Editorial

Back in parliament
Updated 27 Jul, 2024

Back in parliament

It is ECP's responsibility to set right all the wrongs it committed in the Feb 8 general elections.
Brutal crime
27 Jul, 2024

Brutal crime

No effort has been made to even sensitise police to the gravity of crime involving sexual assaults, let alone train them to properly probe such cases.
Upholding rights
27 Jul, 2024

Upholding rights

Sanctity of rights bodies, such as the HRCP, should be inviolable in a civilised environment.
Judicial constraints
Updated 26 Jul, 2024

Judicial constraints

The fact that it is being prescribed by the legislature will be questioned, given the political context.
Macabre spectacle
26 Jul, 2024

Macabre spectacle

Israel knows that regardless of the party that wins the presidency, America’s ‘ironclad’ support for its genocidal endeavours will continue.